2018 Sarcoma Symposium: Emerging Therapies and Diagnostic Strategies for Patients with High Risk and Relapsed Bone and Soft Tissue Sarcoma

Date:  September 7, 2018
Location: The Research Institute at Nationwide Children’s Hospital, Columbus, OH

Registration is free!
Registration: Click here to register to attend


  • Nationwide Children’s Hospital Division of Hematology/Oncology/BMT
  • Nationwide Children’s Hospital Education Institute

Featured Topics

  • Precision Medicine/Genomics
  • Canine Comparative Oncology
  • Radiation Oncology
  • Clinical Trials/New Therapeutic Developments

Keynote Speaker

Abha Gupta, MD, The Hospital for Sick Children 

Katherine A. Janeway, MD, Dana-Farber Cancer Institute

Stephen L. Lessnick, MD, PhD, Nationwide Children’s Hospital Center for Childhood Cancer and Blood Diseases

Lars M. Wagner, MD, University of Kentucky HealthCare

Conference Agenda

Click here to view the full conference agenda.

Conference Directors

The symposium is designed to address novel and emerging treatments of patients with primary metastatic and relapsed bone and soft tissue sarcoma. Despite intensive therapies and incorporation of novel agents, the therapeutic plateau has not been overcome. The aim of this symposium is to review known strategies of care for this patient population with aggressive disease and highlight recent and ongoing advances in the field of sarcoma biology, pre-clinical advances, new clinical trials and also the use of immune-oncology for treatment.

Exhibiting Opportunities

For exhibiting opportunities, please contact Kelly Hallberg at Kelly.Hallberg@NationwideChildrens.org.